Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study

Publication | Open Access

DOI Full Paper Access

Citations

References

2023

Year

Alberto Mateo‐Urdiales, Chiara Sacco, Emmanouil Alexandros Fotakis, Martina Del Manso, Antonino Bella, Flavia Riccardo, Marco Bressi, Maria Cristina Rota, Daniele Petrone, Andrea Siddu,

The Lancet Infectious Diseases

VaccinationViral PersistenceCovid-19 PandemicBivalent Mrna BoostersVaccine EfficacyCohort StudyCovid-19 EpidemiologyInfection ControlPublic HealthMedicineEpidemiologyCovid-19Ba.5 Infection